- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Agitation Associated With Alzheimer’s Dementia Disease State Education

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Agitation Associated With Alzheimer’s Dementia Disease State Education
This is a Virtual Event for PsychU members in Michigan and Ohio.
In this presentation, topics of discussion are:
- Alzheimer’s disease is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population
- Agitation is a common neuropsychiatric symptom of Alzheimer’s dementia and highly prevalent across patient settings and Alzheimer’s disease severities
- The Cohen-Mansfield Agitation Inventory (CMAI) measures the frequency of manifestations of a broad range of agitated behaviors

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
More

Chuck Dillay
Senior Medical Science Liaison, Medical Affairs
Speakers Elizabeth DiNapoli, PhD and Chuck Dillay are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)